Trial results for a study evaluating an analogy-based consultation approach (M2-PRIME) for Type 2 Diabetes patients were posted on ClinicalTrials.gov on 2026-01-23, reporting a mean HbA1c of 10.31% and mean Fasting Blood Sugar of 9.22 mmol/L in the applied group.
Background
Type 2 Diabetes is a chronic condition characterized by insulin resistance and relative insulin deficiency, leading to elevated blood glucose levels. Effective management is crucial to prevent long-term complications affecting the heart, kidneys, eyes, and nerves. For patients on insulin therapy who still experience high blood sugar, as indicated by an HbA1c above 8.5%, achieving better glycemic control remains a significant clinical challenge. Innovative approaches to patient education and consultation are explored to empower patients in managing their condition and improving blood sugar outcomes.
Trial design
This completed study, identified as Phase NA, enrolled 106 participants with Type 2 Diabetes. The trial investigated an analogy-based consultation approach called M2-PRIME, designed to improve blood sugar control in insulin-treated patients with high HbA1c (above 8.5%). The study aimed to determine if M2-PRIME could help lower HbA1c and fasting blood sugar levels. Participants received regular diabetes care at a Self-Monitoring of Blood Glucose (SMBG) clinic, with the M2-PRIME approach integrated into consultations.
Key results
The trial results, posted for the 'M2-PRIME Applied' group, included key measurements for blood sugar control:
- Mean Fasting Blood Sugar (FBS) was 9.22 mmol/L with a Standard Deviation of 4.89.
- Mean HbA1c was 10.31% with a Standard Deviation of 2.01.
What this means
The posted results provide specific mean values for Fasting Blood Sugar and HbA1c in patients with Type 2 Diabetes who underwent the M2-PRIME analogy-based consultation approach. The observed mean HbA1c of 10.31% and mean FBS of 9.22 mmol/L reflect the blood sugar control levels in this group after the intervention. Without comparative data from a control group or baseline measurements, the study's impact on improving blood sugar control cannot be directly assessed from these results alone. However, these figures contribute to the understanding of glycemic profiles in patients receiving this specific consultation method.
Source
The information for these trial results was obtained from ClinicalTrials.gov, a public database of clinical studies. The results for the study NCT07265245, titled 'Evaluating an Analogy-Based Consultation Approach for Insulin-Treated Type 2 Diabetes Patients', were posted on 2026-01-23 on clinicaltrials.gov.